The day provided an opportunity to present the progress made by each unit, including the Bordeaux Institute of Oncology (BRIC)<\/strong>, as well as the unit\u2019s renewal project, led by Fr\u00e9d\u00e9ric Saltel<\/strong>.<\/p>\n\n Established in 2022<\/strong> through the merger of four partner laboratories<\/strong>, BRIC initially comprised eleven research teams<\/strong>. A twelfth team<\/strong>, specialising in kidney cancer, joined the unit during the current term, strengthening ties with Bordeaux University Hospital (CHU de Bordeaux). A thirteenth team <\/strong>is expected to join the project for the next renewal.<\/p>\n\n \u201cWe are strengthening our regional and European partnerships to make BRIC a centre of excellence dedicated to cancer research.\u201d<\/em> \u2013 Fr\u00e9d\u00e9ric Saltel, Director of BRIC<\/strong><\/p>\n<\/blockquote>\n\n BRIC\u2019s teams work across three main research themes:<\/p>\n\n These themes are underpinned by cross-cutting programmes:<\/p>\n\n All teams are affiliated with a hospital department and a healthcare institution (Bordeaux University Hospital or Institut Bergoni\u00e9).<\/p>\n\n Fr\u00e9d\u00e9ric Saltel reaffirmed BRIC<\/strong>\u2019s commitment as coordinator of the ENLIGHT NetCare consortium<\/strong>, which now brings together ten partner universities<\/strong> (compared with four in 2023). The laboratory actively contributes to the organisation of the consortium, fostering collaboration in both research and training.<\/p>\n\n Fr\u00e9d\u00e9ric Saltel presented the activities of the Patient\u2013Society Group, whose objectives are to:<\/p>\n\n Next Steps![\"\"](\"https:\/\/www.bricbordeaux.com\/wp-content\/uploads\/2026\/11\/visite-pdg-inserm-09-11-2026-1024x576.jpg\")
<\/figure>\n\nFocus: The BRIC Laboratory<\/h2>\n\n
\n
\n
Key Points Addressed During the Visit<\/h2>\n\n
Research Projects<\/h3>\n\n
\n
\n
The ENLIGHT European Consortium<\/h3>\n\n
Public Outreach and Patient Partnership<\/h3>\n\n
\n